$20.48
-0.07[-0.34%]
At close: Apr 24
$20.48
0[0.00%]
After Hours: 6:18PM EDT
Cassava Sciences
(NASDAQ:SAVA)Latest News for Cassava Sciences Stock (NASDAQ:SAVA)
Cassava Sciences Stock (NASDAQ: SAVA)
Categories: All
Friday, April 12, 2024
Monday, March 25, 2024
Thursday, March 21, 2024
Monday, March 11, 2024
Tuesday, March 05, 2024
Wednesday, February 28, 2024
Wednesday, February 07, 2024
Monday, January 29, 2024
Monday, January 15, 2024
Thursday, December 21, 2023
Tuesday, December 19, 2023
Tuesday, December 12, 2023
Monday, December 11, 2023
Tuesday, November 07, 2023
Monday, November 06, 2023
Friday, October 27, 2023
Wednesday, October 25, 2023
- Why Cassava Sciences Stock Surged TodayRyan Gustafson - Oct 25, 2023, 3:43PM
- Cassava Sciences shares are trading higher after the company announced MRI data suggested simufilam is not associated with amyloid-related imaging abnormalities.Benzinga Newsdesk - Oct 25, 2023, 2:07PM
- Cassava Sciences, Inc. Announces A Potentially Significant Safety Finding Based On Interim MRI Data Which Suggest Simufilam Is Not Associated With Amyloid-Related Imaging Abnormalities; Safety Finding Based On Blinded MRI Brain Data At Week 40Benzinga Newsdesk - Oct 25, 2023, 9:17AM
Tuesday, October 24, 2023
Thursday, October 19, 2023
Tuesday, October 17, 2023
Friday, October 13, 2023
- Why Belden Shares Are Trading Lower By Over 25%? Here Are Other Stocks Moving In Friday's Mid-Day SessionLisa Levin - Oct 13, 2023, 1:14PM
- UK Authority Approves Microsoft's $69B Activision Blizzard Acquisition, Google Search Gets Generative AI Boost, Big Banks Earnings: Today's Top StoriesVandana Singh - Oct 13, 2023, 9:48AM
- 12 Health Care Stocks Moving In Friday's Pre-Market SessionBenzinga Insights - Oct 13, 2023, 9:06AM
- Cassava Sciences shares are trading lower after a recent report by the City University of New York implicated a long-time collaborator of the company in scientific misconduct related to 20 research papers.Bill Haddad - Oct 13, 2023, 8:27AM
- Alzheimer's-Focused Cassava Sciences Faces Controversy as Key Collaborator Accused of Scientific MisconductVandana Singh - Oct 13, 2023, 7:39AM
- Why Comtech Telecommunications Shares Are Trading Higher By Around 17%; Here Are 20 Stocks Moving PremarketLisa Levin - Oct 13, 2023, 7:35AM
- Outset Medical, SMART Global And Other Big Stocks Moving Lower In Friday's Pre-Market SessionLisa Levin - Oct 13, 2023, 6:37AM
- Cassava Sciences Issues Statement Regarding Leaked Internal CUNY Report, Says No Findings Of Data ManipulationBenzinga Newsdesk - Oct 13, 2023, 3:02AM
Thursday, October 12, 2023
- 12 Health Care Stocks Moving In Thursday's After-Market SessionBenzinga Insights - Oct 12, 2023, 5:31PM
- Shares Of Cassava Sciences Sell Off Sharply After The Publication 'Science' Reported Co-developer Of Cassava's Potential Alzheimer's Drug Cited For 'Egregious MisconductCharles Gross - Oct 12, 2023, 5:30PM
- Adam Feuerstein Tweeted Earlier Co-developer of Cassava's potential Alzheimer's drug cited for 'egregious misconduct'Charles Gross - Oct 12, 2023, 5:09PM
Thursday, October 05, 2023
- President & CEO at Cassava Sciences Acquires Company Stock Options Worth 450,000 SharesBenzinga Insights - Oct 5, 2023, 11:00AM
- Chief Medical Officer at Cassava Sciences Acquires Company Stock Options Worth 150,000 SharesBenzinga Insights - Oct 5, 2023, 11:00AM
- Chief Financial Officer at Cassava Sciences Acquires Company Stock Options Worth 150,000 SharesBenzinga Insights - Oct 5, 2023, 11:00AM